Elan’s Saga Comes To A Close With Perrigo’s $8.6 Billion Bid
This article was originally published in The Pink Sheet
Executive Summary
Perrigo is using Elan’s beneficial tax rates to launch its international expansion and the royalty stream from Tysabri to help fund those M&A endeavors, but is not dramatically changing its OTC focus.